neuroleptic drug, synthesized in the Research Laboratories of Fujisawa Pharmaceutical Co. Ltd. Zotepine is characterized by a weak extrapyramidal effect in humans (1, 2). In animal studies zotepine had a stronger anti serotonergic activity than other neuroleptic drugs (3), although its anti-dopaminergic activity is the same as that of chlorpromazine (4). One of the side effects of neuroleptic drugs is the occasional induction of seizure in schizophrenics (5), but the effect of zotepine on seizure has not been examined. Afterdischarge induced by electrical stimu lation of the limbic system is reported to be a good model for assessing the clinical effect of a drug on seizure, and it is reported to be potentiated by neuroleptic drugs such as chlorpromazine in rats (6) and rabbits (7, 8) . In the present experiment, we examined the comparative effects of zotepine and chlorpromazine on afterdischarge induced by electrical stimulation of the amygdaloid nucleus in rats.
Male Wistar rats used weighed about 200 g at the time of electrode implantation.
Rats anaesthesized with pentobarbital-Na (50 mg/ kg, i.p.) were placed in a stereotaxic ap paratus and were implanted with twisted stainless steel wire electrodes in the cerebral cortex (A: 6.9, L: 3.0), amygdaloid nucleus (A: 5.0, L: 4.5, H: -3.0), and hippocampus (A: 3.0, L: 2.5, H: 2.0), according to De G root (9). Groups of five rats were used for the recording of electroencephalograms by bipolar electrodes on an electroencephalo graph (Nihon Kohden, ME-135D) about 10 days after implantation. Afterdischarge was produced by electrical stimulation of the amygdaloid nucleus with rectangular pulse waves (2-4 V, 40 Hz, 3 msec) delivered by an electric stimulator (San-ei Sokki, ES-103), and the duration of stimulation was 3 sec. Electrical stimulation of the amygdaloid nucleus and recording of afterdischarge were repeated 2 times at 1 hr intervals before dosing with the test drugs. Only those rats which showed almost the same duration of afterdischarge in the two trials were used in the experiment. Soon after the second trials, rats were given zotepine or chlor promazine, and 20 min after dosing, the amygdaloid nucleus was stimulated.
Drugs used were zotepine and chlor promazine hydrochloride (synthesized in our research laboratories). Zotepine was dis solved in a minimum amount of 1 N HCI, adjusted to pH 7 with 1 N NaOH, and diluted with saline to the desired concentration. Chlorpromazine was dissolved in saline. Both drugs were given i.v. in a volume of 5 ml/kg body weight.
Afterdischarge was induced in the cerebral cortex, amygdaloid nucleus, and hip pocampus immediately after electrical stimu lation of the amygdaloid nucleus (first afterdischarge). Occasionally, one or more weak afterdischarges ensued after the disap pearance of the first ones (second after discharge).
At a dose of 1 mg/kg, zotepine and chlorpromazine had no effect on the afterdischarge.
At a dose of 3.2 mg/kg, zotepine shortened the duration of after discharge in three of five rats when compared with that before dosing.
The result is shown in Fig. 1 . In the other two rats, zotepine produced no effect. In contrast, chlor promazine produced 40 and 200% pro longation of the duration of afterdischarge in two of five rats at a dose of 3.2 mg/kg (Fig. 2) . In one rat, a second afterdischarge which was not seen before dosing was induced after dosing with 3.2 mg/kg chlorpromazine.
In the other two rats, afterdischarge was not affected. At a dose of 10 mg/kg, zotepine shortened the duration of afterdischarge in all the rats by 50 to 100% (Fig. 1 ) . In contrast, chlorpromazine in a dose of 10 mg/kg prolonged the duration of afterdischarge by 50% in two of the five rats, produced a newly provoked second after discharge in one rat (Fig. 2) , and had no effect i n the other two rats.
The prolonging effect of chlorpromazine on the duration of afterdischarge has already been reported in rats (6) and rabbits (7, 8 Sci. 66, 784-805 (1957) 11 ) Schallek, W., Zabransky, F. and Kuehn, A.:
Effects of benzodiazepines on central nervous system of cat. Archs int. Pharmacodyn. Ther. 149, 467-483 (1964) 
